AUNA S.A.

LUXEMBOURG--(BUSINESS WIRE)-- Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today that it will host its first Investor Day on Thursday, October 22, 2026. The event will be held in a hybrid format, offering both in-person attendance in Lima, Peru and a live webcast. On-site registration and networking breakfast with management will begin at 9:00 a.m. ET. Management presentations and the live webcast will follow at 10:00 a.m. ET, followed by a Q&A session with members of the executive management team. For in-person attendees, the event will conclude with a luncheon and a tour of Clinica Delgado and Wellness Center in Lima. During the event, Auna’s executive team and country leaders will discuss the Company’s long-term vision, growth strategy across Mexico, Peru and Colombia, financial strategy, and key priorities to drive sustained and profitable growth across its regional healthcare platform. The event is open to investors and sell-side analysts and will be available both in person and via live webcast. Pre-registration is required by October 15, 2026. In-person attendance at the event is limited to investors and sell-side analysts, and the facility tour is subject to venue capacity. To register for the event, please visit aunaday. Registered attendees will receive confirmation and additional event details. A replay of the webcast and presentation materials will be available following the event at aunaday.auna.org. For further information regarding webcast registration, please contact InspIR Group at inspir@inspirgroup.com. For information regarding the in-person event and the site tour, please contact Auna’s Investor Relations team at contact@aunainvestors.com. About AUNA Auna is a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, prioritizing prevention and concentrating on high-complexity diseases that contribute the most to healthcare expenditures. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-Speaking Americas. Founded in 1989, Auna has built one of Latin America’s largest modern healthcare platforms that consists of a horizontally integrated network of healthcare facilities and a vertically integrated portfolio of oncological plans and selected general healthcare plans. As of June 30, 2026, Auna’s network included 31 healthcare facilities, consisting of hospitals, outpatient, prevention and wellness facilities with a total of 2,337 beds, and 1.5 million healthcare plans. For more information, visit www.aunainvestors.com. Cautionary Statement on Forward-Looking Statements

LUXEMBOURG--(BUSINESS WIRE)-- Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today that it will host its first Investor Day on Thursday, October 22, 2026. The event will be held in a hybrid format, offering both in-person attendance in Lima, Peru and a live webcast. On-site registration and networking breakfast with management will begin at 9:00 a.m. ET. Management presentations and the live webcast will follow at 10:00 a.m. ET, followed by a Q&A session with members of the executive management team. For in-person attendees, the event will conclude with a luncheon and a tour of Clinica Delgado and Wellness Center in Lima. During the event, Auna’s executive team and country leaders will discuss the Company’s long-term vision, growth strategy across Mexico, Peru and Colombia, financial strategy, and key priorities to drive sustained and profitable growth across its regional healthcare platform. The event is open to investors and sell-side analysts and will be available both in person and via live webcast. Pre-registration is required by October 15, 2026. In-person attendance at the event is limited to investors and sell-side analysts, and the facility tour is subject to venue capacity. To register for the event, please visit aunaday. Registered attendees will receive confirmation and additional event details. A replay of the webcast and presentation materials will be available following the event at aunaday.auna.org. For further information regarding webcast registration, please contact InspIR Group at inspir@inspirgroup.com. For information regarding the in-person event and the site tour, please contact Auna’s Investor Relations team at contact@aunainvestors.com. About AUNA Auna is a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, prioritizing prevention and concentrating on high-complexity diseases that contribute the most to healthcare expenditures. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-Speaking Americas. Founded in 1989, Auna has built one of Latin America’s largest modern healthcare platforms that consists of a horizontally integrated network of healthcare facilities and a vertically integrated portfolio of oncological plans and selected general healthcare plans. As of June 30, 2026, Auna’s network included 31 healthcare facilities, consisting of hospitals, outpatient, prevention and wellness facilities with a total of 2,337 beds, and 1.5 million healthcare plans. For more information, visit www.aunainvestors.com. Cautionary Statement on Forward-Looking Statements

A consecutive quarter of strong top-line growth and cash flow performance; Consolidated Adjusted EBITDA impacted by service mix across the segments LUXEMBOURG--(BUSINESS WIRE)-- Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the second quarter ended June 30, 2026 (“Second quarter 2026” or “2Q26”). Financial results are expressed in Peruvian Soles (“S/” or “PEN” or “Soles”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted.2Q’26 Consolidated HighlightsRevenue increased 9% FXN, or 13% YoY on a reported basis, to S/1,238 millionAdjusted EBITDA was S/227 million, a decrease of 9% YoY FXN or 6% YoY on a reported basis, and an increase of 3% FXN from 1Q26Adjusted EBITDA Margin of 18.4%, slightly up from 1Q26Operating Cash Flow and Free Cash Flow increased 45% YoY and 181% YoY, respectivelyLeverage Ratio improved to 3.6xOncology MLR remained stable at 50.1%Number of surgeries increased 5.2% YoY to 21,912Number of days hospitalized increased 5% YoY to 135,107Number of chemotherapy and radiotherapy sessions increased 15% YoYMessage from Auna’s Executive Chairman and PresidentThe second quarter of 2026 demonstrated sustained commercial momentum across our markets and progress in the operational initiatives that support our growth strategy. Revenue increased by 9% FXN, while Adjusted EBITDA declined 9% FXN. This reflects service mix and temporary margin pressure in Mexico and Colombia, as well as pharmacy and payroll costs, along with the impact of accepted penalties primarily related to billing matters in the reconciliation of prior years' receivables in Peru.In Peru, our integrated model continues to deliver strong results, Peru achieved an 8% revenue growth, driven by new B2B memberships at Oncosalud and increased volumes in high-complexity procedures within our healthcare network. Oncosalud expanded its B2B membership base, while higher occupancy in the healthcare network underscored our focus on growing in high complexity. Adjusted EBITDA reflects increased pharmacy, physician and payroll expenses required to accommodate the surge in patient volumes, as well as accepted penalties primarily attributable to previous years’ billing matters.In Mexico, patient volume recovery continued throughout the quarter. Improved tier classifications with key payors, improved pricing for high-complexity services, and the ongoing expansion of our oncology offering contributed to stronger volumes, particularly in June. This momentum drove 4% year-over-year revenue growth in local currency, while revenue and Adjusted EBITDA increased by 5% and 3%, respectively, compared to the first quarter of 2026, in local currency. Although service mix and talent investments continued to affect margins year over year, both Adjusted EBITDA and margin improved sequentially, indicating progress in the initiatives underway in Monterrey and positioning the network for sustained volume growth in the second half.In Colombia, revenue increased by 13% in local currency, primarily due to the sustained expansion of risk-sharing (“PGP”) contracts, which accounted for 24% of segment revenue. Additionally, reduced exposure to intervened payors, which constituted 12% of revenue, and enhanced payment agreements contributed to the strengthening of the quality and predictability of our payor mix. First-half margins reflected the variable costs of stabilizing our new PGP contracts, alongside statutory wage increases and planned SG&A invest

A consecutive quarter of strong top-line growth and cash flow performance; Consolidated Adjusted EBITDA impacted by service mix across the segments LUXEMBOURG--(BUSINESS WIRE)-- Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the second quarter ended June 30, 2026 (“Second quarter 2026” or “2Q26”). Financial results are expressed in Peruvian Soles (“S/” or “PEN” or “Soles”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted.2Q’26 Consolidated HighlightsRevenue increased 9% FXN, or 13% YoY on a reported basis, to S/1,238 millionAdjusted EBITDA was S/227 million, a decrease of 9% YoY FXN or 6% YoY on a reported basis, and an increase of 3% FXN from 1Q26Adjusted EBITDA Margin of 18.4%, slightly up from 1Q26Operating Cash Flow and Free Cash Flow increased 45% YoY and 181% YoY, respectivelyLeverage Ratio improved to 3.6xOncology MLR remained stable at 50.1%Number of surgeries increased 5.2% YoY to 21,912Number of days hospitalized increased 5% YoY to 135,107Number of chemotherapy and radiotherapy sessions increased 15% YoYMessage from Auna’s Executive Chairman and PresidentThe second quarter of 2026 demonstrated sustained commercial momentum across our markets and progress in the operational initiatives that support our growth strategy. Revenue increased by 9% FXN, while Adjusted EBITDA declined 9% FXN. This reflects service mix and temporary margin pressure in Mexico and Colombia, as well as pharmacy and payroll costs, along with the impact of accepted penalties primarily related to billing matters in the reconciliation of prior years' receivables in Peru.In Peru, our integrated model continues to deliver strong results, Peru achieved an 8% revenue growth, driven by new B2B memberships at Oncosalud and increased volumes in high-complexity procedures within our healthcare network. Oncosalud expanded its B2B membership base, while higher occupancy in the healthcare network underscored our focus on growing in high complexity. Adjusted EBITDA reflects increased pharmacy, physician and payroll expenses required to accommodate the surge in patient volumes, as well as accepted penalties primarily attributable to previous years’ billing matters.In Mexico, patient volume recovery continued throughout the quarter. Improved tier classifications with key payors, improved pricing for high-complexity services, and the ongoing expansion of our oncology offering contributed to stronger volumes, particularly in June. This momentum drove 4% year-over-year revenue growth in local currency, while revenue and Adjusted EBITDA increased by 5% and 3%, respectively, compared to the first quarter of 2026, in local currency. Although service mix and talent investments continued to affect margins year over year, both Adjusted EBITDA and margin improved sequentially, indicating progress in the initiatives underway in Monterrey and positioning the network for sustained volume growth in the second half.In Colombia, revenue increased by 13% in local currency, primarily due to the sustained expansion of risk-sharing (“PGP”) contracts, which accounted for 24% of segment revenue. Additionally, reduced exposure to intervened payors, which constituted 12% of revenue, and enhanced payment agreements contributed to the strengthening of the quality and predictability of our payor mix. First-half margins reflected the variable costs of stabilizing our new PGP contracts, alongside statutory wage increases and planned SG&A invest

LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Second Quarter 2026 financial results. Earnings Release Tuesday, August 18, 2026 Time: After Market Close Conference Call Wednesday, August 19, 2026 Time: 8:00 a.m. ET Quiet Period Monday, August 3 through Tuesday August 18, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, focusing on high-complexity diseases. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America′s largest modern healthcare platforms that consists of a horizontally integrated network of healthcare facilities and a vertically integrated portfolio of oncological plans and selected general healthcare plans. As of June 30, 2026, Auna’s network included 31 healthcare facilities hospitals, ambulatory centers, and prevention and wellness centers with a total of 2,337 beds and 1.4 million health plan members. For more information visit www.aunainvestors.com Investor Relations Contact contact@aunainvestors.com Source: Auna S.A.

LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Second Quarter 2026 financial results. Earnings Release Tuesday, August 18, 2026 Time: After Market Close Conference Call Wednesday, August 19, 2026 Time: 8:00 a.m. ET Quiet Period Monday, August 3 through Tuesday August 18, 2026 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, focusing on high-complexity diseases. Our mission is to transform healthcare by providing access to a highly integrated healthcare offering in the underpenetrated markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of Latin America′s largest modern healthcare platforms that consists of a horizontally integrated network of healthcare facilities and a vertically integrated portfolio of oncological plans and selected general healthcare plans. As of June 30, 2026, Auna’s network included 31 healthcare facilities hospitals, ambulatory centers, and prevention and wellness centers with a total of 2,337 beds and 1.4 million health plan members. For more information visit www.aunainvestors.com Investor Relations Contact contact@aunainvestors.com Source: Auna S.A.

LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today reported select operating metrics for the Second Quarter ended June 30, 2026. The Company publishes these key performance indicators on a quarterly basis as part of its commitment to providing investors with more information and a clearer understanding of Auna. Preliminary Key Performance IndicatorsAs of second quarter ended June 30, 2026 Healthcare Services Mexico Key Operating Metrics 2Q'25 3Q'25 4Q'25 1Q'26 2Q'26 Emergency treatments(1) # 8,170 7,274 <td class="bwalignr bwpadl0 bw

LUXEMBOURG--(BUSINESS WIRE)-- Auna S.A. (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today reported select operating metrics for the Second Quarter ended June 30, 2026. The Company publishes these key performance indicators on a quarterly basis as part of its commitment to providing investors with more information and a clearer understanding of Auna. Preliminary Key Performance IndicatorsAs of second quarter ended June 30, 2026 Healthcare Services Mexico Key Operating Metrics 2Q'25 3Q'25 4Q'25 1Q'26 2Q'26 Emergency treatments(1) # 8,170 7,274 <td class="bwalignr bwpadl0 bw

Strong top-line growth and cash flow performance; Consolidated Adjusted EBITDA impacted by revenue adjustments; Mexico volumes and revenues growing rapidly, with Segment Adjusted EBITDA increasing 19% QoQ LUXEMBOURG--(BUSINESS WIRE)-- Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the first quarter ended March 31, 2026 (“first quarter 2026” or “1Q26”). Financial results are expressed in Peruvian Soles (“S/” or “PEN” or “Soles”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted.1Q’26 Consolidated HighlightsRevenue increased 10% FXN, or 13% YoY on a reported basis, to S/1,178 millionMexico Revenue increased 15% YoY on a reported basis, to S/ 279 millionAdjusted EBITDA was S/217 million, a decrease of 2% YoYAdjusted EBITDA Margin of 18.4%, down 2.9 p.p. YoY from 21.4% in 1Q25Operating Cash Flow and Free Cash Flow increased 48% YoY and 2.6x YoY, respectivelyLeverage Ratio was stable at 3.7xOncology MLR decreased 2.0 p.p. YoY to 49.6%Number of surgeries increased 4.4% YoY to 21,610Number of days hospitalized increased 2.9% YoY to 132,266Message from Auna’s Executive Chairman and PresidentAuna began 2026 with strong commercial momentum across all three of our markets. First quarter revenues grew 10% FXN, reflecting the impact of the strategic and structural decisions implemented throughout 2025 and further validating the strength of our integrated platform. The AunaWay model continues driving sustainable growth across our markets, with positive underlying operating trends, despite short-term Adjusted EBITDA impacts in Peru and Mexico.In Peru, our integrated healthcare model continued to perform well at scale, delivering solid top-line growth of 9% in local currency, with strong volume increases across hospitals, emergency services, and oncology. Oncosalud maintained its growth trajectory, adding new members and securing a group policy for the nation’s judiciary — a new and prestigious institutional relationship representing nearly 20,000 lives, and contributing to a total of 1.4 million Oncosalud members. While the underlying business dynamic and margin contributions remain stable in Peru, Adjusted EBITDA was impacted in the healthcare services business by delays in pharmacy rebates and revenue adjustments related to certain payors. Oncosalud's MLR of 49.6% in the quarter is consistent with our pricing and MLR management discipline.In Mexico, our healthcare network continues showing strong signs of recovery and our oncology and high-complexity footprint is growing. Sequential Adjusted EBITDA increased 19% from 4Q25 and margins improved 3.5 p.p. The healthcare network delivered 8% year-over-year revenue growth in local currency and the Monterrey operational initiatives gained further traction. Patient volumes increased 13% quarter-over-quarter, as our growing relationships with payors and our commitment to contain costs for them, while improving patient experiences and medical resolutions are producing higher revenues across service lines. Our oncology business grew 32% from 4Q25 representing 11% of Mexico network revenues, up from 4% one year ago. These trends reflect the impact of the growth initiatives implemented under our new Monterrey leadership team and are delivering clear results.In Colombia, revenue grew 14% in local currency, PGP risk-sharing contracts now represent 21% of total revenues, and revenues from intervened payors have decreased from 19% to 14% versus the fir

Strong top-line growth and cash flow performance; Consolidated Adjusted EBITDA impacted by revenue adjustments; Mexico volumes and revenues growing rapidly, with Segment Adjusted EBITDA increasing 19% QoQ LUXEMBOURG--(BUSINESS WIRE)-- Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the first quarter ended March 31, 2026 (“first quarter 2026” or “1Q26”). Financial results are expressed in Peruvian Soles (“S/” or “PEN” or “Soles”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted.1Q’26 Consolidated HighlightsRevenue increased 10% FXN, or 13% YoY on a reported basis, to S/1,178 millionMexico Revenue increased 15% YoY on a reported basis, to S/ 279 millionAdjusted EBITDA was S/217 million, a decrease of 2% YoYAdjusted EBITDA Margin of 18.4%, down 2.9 p.p. YoY from 21.4% in 1Q25Operating Cash Flow and Free Cash Flow increased 48% YoY and 2.6x YoY, respectivelyLeverage Ratio was stable at 3.7xOncology MLR decreased 2.0 p.p. YoY to 49.6%Number of surgeries increased 4.4% YoY to 21,610Number of days hospitalized increased 2.9% YoY to 132,266Message from Auna’s Executive Chairman and PresidentAuna began 2026 with strong commercial momentum across all three of our markets. First quarter revenues grew 10% FXN, reflecting the impact of the strategic and structural decisions implemented throughout 2025 and further validating the strength of our integrated platform. The AunaWay model continues driving sustainable growth across our markets, with positive underlying operating trends, despite short-term Adjusted EBITDA impacts in Peru and Mexico.In Peru, our integrated healthcare model continued to perform well at scale, delivering solid top-line growth of 9% in local currency, with strong volume increases across hospitals, emergency services, and oncology. Oncosalud maintained its growth trajectory, adding new members and securing a group policy for the nation’s judiciary — a new and prestigious institutional relationship representing nearly 20,000 lives, and contributing to a total of 1.4 million Oncosalud members. While the underlying business dynamic and margin contributions remain stable in Peru, Adjusted EBITDA was impacted in the healthcare services business by delays in pharmacy rebates and revenue adjustments related to certain payors. Oncosalud's MLR of 49.6% in the quarter is consistent with our pricing and MLR management discipline.In Mexico, our healthcare network continues showing strong signs of recovery and our oncology and high-complexity footprint is growing. Sequential Adjusted EBITDA increased 19% from 4Q25 and margins improved 3.5 p.p. The healthcare network delivered 8% year-over-year revenue growth in local currency and the Monterrey operational initiatives gained further traction. Patient volumes increased 13% quarter-over-quarter, as our growing relationships with payors and our commitment to contain costs for them, while improving patient experiences and medical resolutions are producing higher revenues across service lines. Our oncology business grew 32% from 4Q25 representing 11% of Mexico network revenues, up from 4% one year ago. These trends reflect the impact of the growth initiatives implemented under our new Monterrey leadership team and are delivering clear results.In Colombia, revenue grew 14% in local currency, PGP risk-sharing contracts now represent 21% of total revenues, and revenues from intervened payors have decreased from 19% to 14% versus the fir